• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-2α/溶血磷脂酰胆碱酰基转移酶1通过调节FBXW7介导的ATP柠檬酸裂解酶泛素化来协调肾透明细胞癌中脂质代谢的重编程。

HIF-2α/LPCAT1 orchestrates the reprogramming of lipid metabolism in ccRCC by modulating the FBXW7-mediated ubiquitination of ACLY.

作者信息

Fei Mintian, Zhang Yi, Li Haolin, Xu Qili, Gao Yu, Yang Cheng, Li Weiyi, Liang Chaozhao, Wang Baojun, Xiao Haibing

机构信息

Department of Urology, the First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, PR China.

Institute of Urology, Anhui Medical University, Hefei, Anhui, PR China.

出版信息

Int J Biol Sci. 2025 Jan 1;21(2):614-631. doi: 10.7150/ijbs.103032. eCollection 2025.

DOI:10.7150/ijbs.103032
PMID:39781455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11705634/
Abstract

The current research revealed a strong link between lipid reprogramming and dysregulated lipid metabolism to the genesis and development of clear cell renal cell carcinoma (ccRCC). Pathologically, ccRCC exhibits a high concentration of lipid droplets within the cytoplasm. HIF-2α expression has previously been demonstrated to be elevated in ccRCC caused by mutations in the von Hippel-Lindau (VHL) gene, which plays a vital role in the development of renal cell carcinoma. Nevertheless, the mechanisms by which HIF-2α influences lipid metabolism reprogramming are unknown. Our investigation demonstrated that HIF-2α directly binds to the promoter region of LPCAT1, promoting its transcription. RNA-seq and lipidomics mass spectrometry studies showed that knocking down LPCAT1 significantly reduced triglyceride production. Research suggests that KD-LPCAT1 involves activation of the NF-κB signaling pathway, which activates F-Box/WD Repeat-Containing Protein 7 (FBXW7). FBXW7, an E3 ubiquitin ligase involved in lipid metabolism, interacts with ATP Citrate Lyase (ACLY) to promote its degradation, lowering fatty acid production and contributing to the lipid content reduction.

摘要

目前的研究揭示了脂质重编程和脂质代谢失调与透明细胞肾细胞癌(ccRCC)的发生发展之间存在紧密联系。在病理上,ccRCC在细胞质内表现出高浓度的脂滴。先前已证明,在由冯·希佩尔-林道(VHL)基因突变引起的ccRCC中,缺氧诱导因子-2α(HIF-2α)表达升高,而VHL基因在肾细胞癌的发展中起着至关重要的作用。然而,HIF-2α影响脂质代谢重编程的机制尚不清楚。我们的研究表明,HIF-2α直接结合溶血磷脂酰胆碱酰基转移酶1(LPCAT1)的启动子区域,促进其转录。RNA测序和脂质组学质谱研究表明,敲低LPCAT1可显著降低甘油三酯的产生。研究表明,敲低LPCAT1涉及核因子κB(NF-κB)信号通路的激活,该通路激活含F-Box/ WD重复序列蛋白7(FBXW7)。FBXW7是一种参与脂质代谢的E3泛素连接酶,它与ATP柠檬酸裂解酶(ACLY)相互作用以促进其降解,降低脂肪酸生成并导致脂质含量减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/6588ddbabf11/ijbsv21p0614g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/be7a2ef73f4a/ijbsv21p0614g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/1b0049e3d97d/ijbsv21p0614g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/d3087be33de5/ijbsv21p0614g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/42796f079b0e/ijbsv21p0614g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/12977dd015c6/ijbsv21p0614g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/e830f092f04a/ijbsv21p0614g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/92265e6bebea/ijbsv21p0614g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/6588ddbabf11/ijbsv21p0614g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/be7a2ef73f4a/ijbsv21p0614g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/1b0049e3d97d/ijbsv21p0614g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/d3087be33de5/ijbsv21p0614g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/42796f079b0e/ijbsv21p0614g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/12977dd015c6/ijbsv21p0614g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/e830f092f04a/ijbsv21p0614g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/92265e6bebea/ijbsv21p0614g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/11705634/6588ddbabf11/ijbsv21p0614g008.jpg

相似文献

1
HIF-2α/LPCAT1 orchestrates the reprogramming of lipid metabolism in ccRCC by modulating the FBXW7-mediated ubiquitination of ACLY.缺氧诱导因子-2α/溶血磷脂酰胆碱酰基转移酶1通过调节FBXW7介导的ATP柠檬酸裂解酶泛素化来协调肾透明细胞癌中脂质代谢的重编程。
Int J Biol Sci. 2025 Jan 1;21(2):614-631. doi: 10.7150/ijbs.103032. eCollection 2025.
2
Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.依米丁促进肾透明细胞癌中缺氧诱导因子-2α的 von Hippel-Lindau 非依赖性降解。
Mol Pharmacol. 2010 Dec;78(6):1072-8. doi: 10.1124/mol.110.066514. Epub 2010 Sep 2.
3
HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma.缺氧诱导因子-2α(HIF-2α)的表达和代谢信号需要酰基辅酶 A 合成酶 2(ACSS2)在透明细胞肾细胞癌中发挥作用。
J Clin Invest. 2024 Jun 17;134(12):e164249. doi: 10.1172/JCI164249.
4
[The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].[缺氧诱导因子-1、2α在散发性透明细胞肾细胞癌中的表达及其与冯·希佩尔-林道基因变异的关系]
Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):390-3.
5
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.肾透明细胞癌程序性死亡配体 1 是缺氧诱导因子-2α的新的直接靶标,受 von Hippel-Lindau 基因突变状态调控。
Eur Urol. 2016 Oct;70(4):623-632. doi: 10.1016/j.eururo.2015.11.029. Epub 2015 Dec 23.
6
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.缺氧、缺氧诱导转录因子与肾癌
Eur Urol. 2016 Apr;69(4):646-657. doi: 10.1016/j.eururo.2015.08.007. Epub 2015 Aug 19.
7
The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.von Hippel-Lindau 肿瘤抑制蛋白促进 c-Cbl 非依赖性的 EGFR 激活体多泛素化和降解。
PLoS One. 2011;6(9):e23936. doi: 10.1371/journal.pone.0023936. Epub 2011 Sep 16.
8
HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species.CDK4/6 抑制与 VHL 缺失在物种间的 HIF 非依赖性合成致死作用。
Sci Signal. 2019 Oct 1;12(601):eaay0482. doi: 10.1126/scisignal.aay0482.
9
CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.CDK1/FBXW7 促进 MLST8 的降解和泛素化,从而抑制肾细胞癌的进展。
Cancer Sci. 2022 Jan;113(1):91-108. doi: 10.1111/cas.15188. Epub 2021 Nov 16.
10
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.铁螯合对透明细胞肾细胞癌的抑制作用及其对 VHL 失活的依赖性。
Free Radic Biol Med. 2019 Mar;133:295-309. doi: 10.1016/j.freeradbiomed.2018.12.013. Epub 2018 Dec 13.

引用本文的文献

1
Identification of CENPW as a prognostic biomarker and potential therapeutic target for clear cell renal cell carcinoma.鉴定CENPW作为透明细胞肾细胞癌的预后生物标志物和潜在治疗靶点。
Discov Oncol. 2025 Jun 18;16(1):1138. doi: 10.1007/s12672-025-02859-8.
2
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma.肾细胞癌中代谢重编程的发病机制及治疗意义
Cell Death Discov. 2025 Apr 19;11(1):186. doi: 10.1038/s41420-025-02479-9.

本文引用的文献

1
Clinical significance, molecular characterization, and immune microenvironment analysis of coagulation-related genes in clear cell renal cell carcinoma.透明细胞肾细胞癌中凝血相关基因的临床意义、分子特征及免疫微环境分析
Cancer Innov. 2024 Jan 7;3(1):e105. doi: 10.1002/cai2.105. eCollection 2024 Feb.
2
Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.SCF E3 泛素连接酶的肿瘤抑制作用的分子见解和临床意义。
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189140. doi: 10.1016/j.bbcan.2024.189140. Epub 2024 Jun 21.
3
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
肿瘤免疫微环境中的代谢重编程:对免疫细胞功能的影响及其治疗意义。
Cancer Lett. 2024 Aug 10;597:217076. doi: 10.1016/j.canlet.2024.217076. Epub 2024 Jun 19.
4
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC.脂质代谢重编程的全面分析拓展了肝癌的精准医学。
Hepatology. 2025 Apr 1;81(4):1164-1180. doi: 10.1097/HEP.0000000000000962. Epub 2024 Jun 19.
5
Von Hippel-Lindau protein signalling in clear cell renal cell carcinoma.von Hippel-Lindau 蛋白信号在透明细胞肾细胞癌中的作用。
Nat Rev Urol. 2024 Nov;21(11):662-675. doi: 10.1038/s41585-024-00876-w. Epub 2024 May 2.
6
LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth.LPCAT1 介导的膜脂重塑促进了铁死亡逃逸和肿瘤生长。
Nat Cell Biol. 2024 May;26(5):811-824. doi: 10.1038/s41556-024-01405-y. Epub 2024 Apr 26.
7
MED15 is upregulated by HIF-2α and promotes proliferation and metastasis in clear cell renal cell carcinoma via activation of SREBP-dependent fatty acid synthesis.MED15 被缺氧诱导因子-2α上调,并通过激活固醇调节元件结合蛋白(SREBP)依赖的脂肪酸合成促进透明细胞肾细胞癌的增殖和转移。
Cell Death Discov. 2024 Apr 22;10(1):188. doi: 10.1038/s41420-024-01944-1.
8
Lysophospholipid acyltransferase-mediated formation of saturated glycerophospholipids maintained cell membrane integrity for hypoxic adaptation.溶血磷脂酰基转移酶介导的饱和甘油磷脂形成维持了细胞膜完整性以适应缺氧。
FEBS J. 2024 Jul;291(14):3191-3210. doi: 10.1111/febs.17132. Epub 2024 Apr 11.
9
Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC.鉴定 CTBP1-DT 为一种免疫生物标志物,可促进 KIRC 中的脂质合成和抗细胞凋亡。
Gene. 2024 Jul 1;914:148403. doi: 10.1016/j.gene.2024.148403. Epub 2024 Mar 21.
10
The pseudokinase TRIB3 controls adipocyte lipid homeostasis and proliferation in vitro and in vivo.TRIB3 假激酶在体外和体内控制脂肪细胞的脂质稳态和增殖。
Mol Metab. 2023 Dec;78:101829. doi: 10.1016/j.molmet.2023.101829. Epub 2023 Oct 30.